Dr Jim Rybacki's blog

Xarelto (rivaroxaban) on the agenda today for review for use in heart attacks (ACS)

dr rybacki Xarelto (rivaroxaban) is on the agenda of the FDA expert committee for possible recommendation for approval for use in heart attack and unstable angina.

National Women's Health Week but where is the media ???

2 women It’s National Women’s Health week—yet the networks barely covered this? The concept is simple. Bring together communities, businesses, government and other groups to promote women’s health.

FDA approves generic Plavix (clopidogrel) in a major after heart attack decision

king on a chess board As predicted in The Essential Guide to Prescription Drugs, 12 Top Meds for 2012, the FDA today approved the first generic form of Plavix (clopidogrel).

Be honest about your pain

Dr. Rybacki skeptical  Pain is now the fifth vital sign. When you are in the hospital, pain is supposed to be regularly checked and if the pain is at an unacceptable level, treatment needs to be given and then the results from that treatment rechecked.

This website is not intended as medical advice, and you should consult your doctor before changing or adding any medicines or vitamins to those you may now be taking and about applying any strategies BEFORE you adopt any approach in this report. While diligent care has been taken to ensure the accuracy of the information provided during the preparation of this edition, no claim is made that all known actions, uses or side effects, strategies for cost containment, targets or cholesterol pathways are included in this report. The accuracy and currentness of information are ever subject to change relative to new guidelines, new information derived from drug research, development and general usage.